Skip to main content
BFRG
NASDAQ Life Sciences

BullFrog AI Fails Nasdaq Equity Requirement Extension, Faces Delisting

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.588
Mkt Cap
$6.116M
52W Low
$0.425
52W High
$3.38
52W Position info
38% above low
Off High info
83% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BFRG sits 38% above its 52-week low of $0.425.

Summary

BullFrog AI Holdings, Inc. received notice from Nasdaq that it failed to meet the terms of its extension for the minimum stockholders' equity requirement, making its securities subject to delisting.


Key Events · Corporate Governance and Compliance · BFRG

  • Failed to Meet Nasdaq Extension Terms

    The company received notice from Nasdaq on February 19, 2026, that it had not met the terms of the extension granted to comply with the minimum $2,500,000 stockholders' equity requirement.

  • Subject to Delisting

    As a result of failing the extension terms, the company's securities are now subject to delisting from The Nasdaq Capital Market.

  • Intends to Request Hearing

    BullFrog AI plans to timely request a hearing before an independent Nasdaq Hearings Panel, which will automatically stay any suspension or delisting action pending the hearing.

  • Significant Risk of Delisting

    There is no assurance that the Panel will grant additional time or that the company will ultimately regain compliance, with delisting posing severe risks to liquidity and capital raising.


Analysis · BFRG · Life Sciences

BullFrog AI Holdings, Inc. has failed to meet the terms of its Nasdaq extension for the minimum stockholders' equity requirement, putting its listing at severe risk. This follows an initial notice in August 2025 and an extension granted until February 2026. While the company intends to request a hearing, there is no guarantee of a further extension or successful compliance. Delisting would significantly impair the company's ability to raise capital and could lead to a material decline in stock price, posing a critical threat to its operational viability.

At the time of this filing, BFRG was trading at $0.59 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.1M. The 52-week trading range was $0.43 to $3.38. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BFRG - Latest Insights

BFRG
Jul 06, 2026, 4:00 PM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.698
Real-time Price: $0.600 info
Change: -$0.098 (-14%) info
Market Cap: $11.305M info
BFRG
Jun 15, 2026, 5:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.6387
Real-time Price: $0.600 info
Change: -$0.0387 (-6%) info
Market Cap: $11.305M info
BFRG
May 29, 2026, 4:34 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $0.7551
Real-time Price: $0.600 info
Change: -$0.1551 (-21%) info
Market Cap: $11.305M info
BFRG
May 14, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.602
Real-time Price: $0.600 info
Change: -$0.0020 (-0.33%) info
Market Cap: $11.305M info
BFRG
Apr 13, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.01
Real-time Price: $0.600 info
Change: -$0.410 (-41%) info
Market Cap: $11.305M info